2.74BUSD
See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US14888U1016
CUSIP
14888U101
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
14.32
PEG Ratio
-
Book Value
6.51
Dividend Share
-
Dividend Yield
-
Earnings Share
1.57
Wall Street Target Price
34.29
EPS Estimate Current Year
2.10
EPS Estimate Next Year
2.35
EPS Estimate Current Quarter
0.5267
EPS Estimate Next Quarter
0.5032
Most Recent Quarter
-
Revenue TTM
534,646,016
Gross Profit TTM
446,456,000
EBITDA
269,168,992
Profit Margin
36.91%
Return On Assets TTM
18.59%
Return On Equity TTM
29.11%
Revenue Per Share TTM
4.469
Qtly Revenue Growth YOY
43.60%
Diluted Eps TTM
1.57
Qtly Earnings Growth YOY
136.80%
Trailing PE
14.32
Forward PE
12
Price Sales TTM
5.1286
Price Book MRQ
3.4522
Enterprise Value Revenue
4
Enterprise Value EBITDA
8
90.45
1.63%316.89
1.54%188.94
1.42%547.46
0.96%443.00
0.49%511.00
0.35%586.54
0.00%148.56
0.00%246.69
-2.42%77.85
-1.44%